11.12.2017 Views

QYResearch: In 2016, global revenue of insulin pump is nearly 1218 M USD

http://www.qyresearchglobal.com/goods-792375.html The global average price of insulin pump is in the decreasing trend, from 5256 USD/Unit in 2011 to 4936 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.

http://www.qyresearchglobal.com/goods-792375.html
The global average price of insulin pump is in the decreasing trend, from 5256 USD/Unit in 2011 to 4936 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>QYResearch</strong><br />

<strong>QYResearch</strong> focus on Market Survey and Research<br />

www.qyresearch<strong>global</strong>.com


Beijing Hengzhou Bozhi <strong>In</strong>ternational <strong>In</strong>formation Consulting<br />

Web: qyresearch<strong>global</strong>.com | qyresearcheurope.com |<br />

qyresearch.com | qyresearch.com/engl<strong>is</strong>h |<br />

qyresearchjapan.com<br />

TEL: +86-13660489419, Office: +86-2086655165<br />

Media: press@qyresearch.com<br />

Marketing: sales@qyresearch.com<br />

Facebook: @<strong>QYResearch</strong>Official, Twitter: @<strong>QYResearch</strong>_<br />

Wechat Official Account: <strong>QYResearch</strong>, Weibo: 恒 州 博 智<br />

www.qyresearch<strong>global</strong>.com


<strong>QYResearch</strong><br />

An <strong>insulin</strong> <strong>pump</strong> <strong>is</strong> a medical device used<br />

for the admin<strong>is</strong>tration <strong>of</strong> <strong>insulin</strong> in the<br />

treatment <strong>of</strong> diabetes mellitus, also known<br />

as continuous subcutaneous <strong>insulin</strong><br />

infusion therapy. The device configuration<br />

may vary depending on design. A<br />

traditional <strong>pump</strong> includes: the <strong>pump</strong><br />

(including controls, processing module,<br />

and batteries); a d<strong>is</strong>posable reservoir for<br />

<strong>insulin</strong> (inside the <strong>pump</strong>) a d<strong>is</strong>posable<br />

infusion set, including a cannula for<br />

subcutaneous insertion (under the skin)<br />

and a tubing system to interface the<br />

<strong>insulin</strong> reservoir to the cannula.<br />

www.qyresearch<strong>global</strong>.com


<strong>QYResearch</strong><br />

<strong>In</strong> the last several years, <strong>global</strong> market <strong>of</strong> <strong>insulin</strong> <strong>pump</strong> developed smoothly, with an<br />

average growth rate <strong>of</strong> 5.2%. <strong>In</strong> <strong>2016</strong>, <strong>global</strong> <strong>revenue</strong> <strong>of</strong> <strong>insulin</strong> <strong>pump</strong> <strong>is</strong> <strong>nearly</strong> <strong>1218</strong> M <strong>USD</strong>;<br />

the actual production <strong>is</strong> about 246 K units.<br />

The <strong>global</strong> average price <strong>of</strong> <strong>insulin</strong> <strong>pump</strong> <strong>is</strong> in the decreasing trend, from 5256 <strong>USD</strong>/Unit in<br />

2011 to 4936 <strong>USD</strong>/Unit in <strong>2016</strong>. With the situation <strong>of</strong> <strong>global</strong> economy, prices will be in<br />

decreasing trend in the following five years.<br />

The classification <strong>of</strong> <strong>In</strong>sulin Pump includes normal and patch <strong>pump</strong>, and the proportion <strong>of</strong><br />

normal in <strong>2016</strong> <strong>is</strong> about 82%.<br />

<strong>In</strong>sulin <strong>pump</strong> <strong>is</strong> widely used to treat Type I diabetes and Type II diabetes. The most<br />

proportion <strong>of</strong> <strong>insulin</strong> <strong>pump</strong> <strong>is</strong> used for Type I diabetes treatment, and the consumption<br />

proportion in <strong>2016</strong> <strong>is</strong> about 81%.<br />

North America region <strong>is</strong> the largest supplier <strong>of</strong> <strong>insulin</strong> <strong>pump</strong>, with a production market<br />

share <strong>nearly</strong> 65% in <strong>2016</strong>. Europe <strong>is</strong> the second largest supplier <strong>of</strong> <strong>insulin</strong> <strong>pump</strong>, enjoying<br />

production market share <strong>nearly</strong> 19% in <strong>2016</strong>.<br />

www.qyresearch<strong>global</strong>.com


<strong>QYResearch</strong> PART 1<br />

请 输 入 你 的 标 题<br />

North America <strong>is</strong> the largest consumption<br />

place, with a consumption market share<br />

<strong>nearly</strong> 34% in <strong>2016</strong>. Following North<br />

America, Europe <strong>is</strong> the second largest<br />

consumption place with the consumption<br />

market share <strong>of</strong> 24% in <strong>2016</strong>.<br />

Market competition <strong>is</strong> intense. Medtronic,<br />

Johnson & Johnson, Roche, etc. are the<br />

leaders <strong>of</strong> the industry, and they hold key<br />

technologies and patents, with high-end<br />

customers; have been formed in the monopoly<br />

position in the industry.<br />

Full Report Link: http://www.qyresearch<strong>global</strong>.com/goods-792375.html<br />

www.qyresearch<strong>global</strong>.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!